Search - tctmd.com

Displaying 161 - 180 of 879

Sort: Relevancy | Date

Presentation TCT 2019

Regulatory Considerations for High Bleeding Risk Patients Undergoing PCI

Presenter: Adrian Magee

September 27, 2019

Presentation TCT 2019

Defining High Bleeding Risk: HBR ARC

Presenter: Philip Urban

September 27, 2019

Presentation TCT 2019

PICCOLETO II: 6-Month Clinical and Angiographic Findings From a Randomized Trial of Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Small Vessel Coronary Artery Disease

Presenter: Bernardo Cortese

September 27, 2019

Presentation TCT 2019

Some Stents Are More Equal Than Others (e.g., Ultra-Thin)!

Presenter: David Kandzari

September 27, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

Presentation TCT 2019

Using Dedicated Bifurcation Stents in Clinical Practice

Presenter: Carlo Briguori

September 26, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

News Conference News TCT 2019

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

L.A. McKeown

September 26, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

Presentation TCT 2019

Primer on Metallic Stents Developed in India

Presenter: Upendra Kaul

September 26, 2019

Presentation TCT 2019

Restoring Damaged Arteries With Regenerative Stents (STENTiT)

Presenter: Mari Sol Cabrera

September 26, 2019

Presentation TCT 2019

Primer on Metallic Stents Developed in China

Presenter: Run-Lin Gao

September 26, 2019

Presentation TCT 2019

Pro-Healing Stents (With Active and Passive Coatings): Latest Clinical Evidence

Presenter: Robert de Winter

September 26, 2019

Opening Debate: Which Metallic DES Should Be on My Cath Lab Shelf? - Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Presentation TCT 2019

Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Presenter: David Kandzari

September 26, 2019

Opening Debate: Which Metallic DES Should Be on My Cath Lab Shelf? - Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Presentation TCT 2019

Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years

Presenter: Mamas Mamas

September 26, 2019

Presentation TCT 2019

TCT 98: Five-Year Clinical Results of Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion

Presenter: Lei Song

September 25, 2019

Presentation TCT 2019

TCT 56: Impact of Neoatherosclerosis on clinical Outcomes after Repeat Revascularization of In-Stent Restenosis of 2nd Generation Drug-Eluting Stents

Presenter: Zhaoyang Chen

September 25, 2019

Presentation TCT 2019

TCT 47: Five-Year Clinical Outcomes From Randomized Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial

Presenter: Run-Lin Gao

September 25, 2019

Advertisement

Regulatory Considerations for High Bleeding Risk Patients Undergoing PCI

Defining High Bleeding Risk: HBR ARC

PICCOLETO II: 6-Month Clinical and Angiographic Findings From a Randomized Trial of Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Small Vessel Coronary Artery Disease

Some Stents Are More Equal Than Others (e.g., Ultra-Thin)!

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Using Dedicated Bifurcation Stents in Clinical Practice

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Primer on Metallic Stents Developed in India

Restoring Damaged Arteries With Regenerative Stents (STENTiT)

Primer on Metallic Stents Developed in China

Pro-Healing Stents (With Active and Passive Coatings): Latest Clinical Evidence

Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years

TCT 98: Five-Year Clinical Results of Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion

TCT 56: Impact of Neoatherosclerosis on clinical Outcomes after Repeat Revascularization of In-Stent Restenosis of 2nd Generation Drug-Eluting Stents

TCT 47: Five-Year Clinical Outcomes From Randomized Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content